Articles tagged with Muscle Diseases
Researchers discovered a new mechanism by which leiomodin builds actin filaments in muscles, challenging a long-standing paradigm. This breakthrough may lead to therapies for dilated cardiomyopathy and other muscle diseases.
A phase 3 trial found that deramiocel, a heart-derived cellular therapy, slowed muscle weakening and preserved heart function in boys and young men with advanced Duchenne muscular dystrophy. The therapy also showed promise in reducing scarring in the heart.
The IOF Musculoskeletal Rare Diseases Training Course bridges latest scientific advances with current clinical guidance, covering disorders-specific programs. Clinicians can access high-quality educational content at their own pace to deepen expertise in rare skeletal conditions diagnosis and management.
Researchers identified two parallel neuronal circuits regulating autophagy-lysosome pathway in C. elegans body wall muscle. The first circuit involves electrical synapses and the second originates from ASI sensory neurons, both converging on a Ca2+-calpain-lysosome signaling cascade to maintain muscle homeostasis.
A new study published in The Lancet found that a dual-mobility total hip replacement (DM THR) can reduce the risk of complications, including joint dislocations, by up to 70%. This breakthrough implant design consists of a small ball encased in a larger plastic ball, providing better stability and reducing surgical complications.
The study reveals how genetic mutations disrupt muscle signaling in CMS, a family of genetic disorders that weaken communication between nerves and muscles. Researchers identified promising new therapeutic opportunities, including a potential use for an existing antidepressant.
A CU Anschutz study reveals reduced mitochondrial efficiency in healthy yet sedentary individuals, which may precede the development of major diseases like cancer, diabetes, and Alzheimer's. Regular exercise acts as a literal shield for cellular health, helping mitochondria seamlessly switch between burning fat and carbohydrates.
Researchers at UT MD Anderson Cancer Center have achieved high response rates in patients with hard-to-treat acute myeloid leukemia (AML) using an all-oral combination therapy. The study also provides insights into the origins of cancer, revealing that tumors evolve rapidly through bursts of genetic changes.
Researchers developed a novel gene therapy platform that successfully restored muscle function in preclinical models of Duchenne muscular dystrophy by delivering full-length mRNA of the DMD gene via engineered extracellular vesicles. The treatment showed improved muscle strength, endurance, and function without serious side effects.
Climate change is likely to spread chikungunya virus into temperate regions like northeastern North America, central Europe, and East Asia, with the Asian tiger mosquito playing a key role in transmission. Public health officials should prepare by tracking mosquitoes, training doctors, and strengthening control measures by 2040.
A major new study has found that severe asthma patients are often battling other health conditions, with nearly all suffering from at least one major issue. The study identified three distinct profiles linked to how well asthma is controlled and the treatments needed, offering potential breakthroughs for improving care.
The Korea University College of Medicine Myokine Research Center has signed a MOU with MFC to jointly develop therapeutics for muscle loss in astronauts. The center aims to preserve muscle health in long-duration deep space missions, including Mars exploration.
Researchers at Nagoya University found that a brief spike in testosterone after birth causes muscle-wasting disease to develop decades later. Treating the disease at birth significantly reduced nerve cell breakdown in adult mice.
The ESE and ESPE have launched a landmark Joint Clinical Practice Guidance to support structured and effective transition of young people with endocrine conditions. The Guidance provides practical, evidence-based recommendations to ensure continuity, safety and quality of care during this critical phase in a patient's life.
Researchers identified ApoE as a systemic inhibitor of bone repair during aging, and showed that blocking its activity can restore bone regeneration and improve fracture healing. The study provides hope for therapies that actively restore regenerative capacity in older patients, reducing nonunion risk and improving recovery.
A team at Chalmers University of Technology has discovered biomarkers for Parkinson's disease in the blood, which could lead to early diagnosis via blood tests within five years. The study found distinct gene activities linked to DNA damage repair and stress response in patients in the early phase of the disease.
A severe form of muscular dystrophy has been found to impair muscle regeneration, with researchers identifying a genetic defect that affects laminin-α2 protein production. This discovery opens up new avenues for therapies targeting both muscle fibers and stem cells to slow disease progression.
The UBC robotic platform helps scientists understand how the brain keeps us standing by mimicking delays in sensory feedback. By tweaking forces and adding short delays, the robot reveals that our sense of space and time work from the same playbook.
Researchers at Cincinnati Children's Hospital Medical Center have discovered a shared mechanism that may help improve healing across several types of muscle injury. Macrophages, immune cells known as microscopic garbage trucks, deliver ions to muscle fibers, facilitating rapid repair after an injury.
A new urine test can detect SORD deficiency, a common cause of inherited nerve disease, earlier and more cheaply than genetic tests. The test has brought understanding and access to care for affected families, particularly in the Old Order Amish community.
Researchers at UMC Utrecht are developing a predictive model to accurately predict disease progress in juvenile dermatomyositis. The Interferon Score aims to identify which children can safely reduce medication and which require intensified treatment.
Researchers at Sanford Burnham Prebys have developed a new method to generate more and potent skeletal muscle progenitor cells. The study found that blocking the activity of Janus kinase 2 (JAK2) yields a twofold increase in cell yield, while also delivering more mature and effective cells for regenerative medicine treatment.
Pennington Biomedical researchers will participate in numerous panels and presentations during the conference, sharing their latest findings on obesity treatment and prevention. The institution is well-represented at the event, with faculty members among the experts leading courses, presentations, and speaker panels.
A new study published in Nature's Scientific Reports indicates that ALS and MS have a high geographic association, even after controlling for demographic factors. The research suggests an environmental factor likely plays a significant role in both diseases.
Researchers found that large MAF family transcription factors can reactivate the dormant 'Type IIb fast-twitch program' in human muscle, leading to improved glycolytic capacity and increased exercise capacity. Athletes with higher expression levels of these factors had faster and more powerful movements.
A new study reveals that population aging is the largest contributor to musculoskeletal disorders globally, accounting for approximately one third of countries and territories. The research highlights the need for targeted public health strategies and healthcare resource allocation to alleviate the burden of these disorders.
A new review emphasizes the importance of both physical activity and reduced sedentary time for optimal skeletal health. Emerging evidence reveals that prolonged sitting and inactivity can harm bone health, even among regular exercisers.
Researchers Kevin Campbell, Louis Kunkel, and Eric Olson are honored for their discoveries revealing the biological causes of Duchenne muscular dystrophy, providing a foundation for new treatments. Their work has advanced scientific understanding and brings hope to families affected by this devastating disease.
The initiative aims to uncover critical genetic and metabolic mechanisms that may explain the increased incidence of ALS among high-performing populations. By using remote-participation technology, up to 500 participants will be collected, eliminating logistical barriers and expanding who can take part in research.
Scientists have discovered that MYOD protein can act as a gene silencer, clearing out old 'furniture' to reset the cell's identity. This finding challenges dogma and opens up new avenues for understanding cellular reprogramming and regenerative medicine therapies.
Answer ALS has launched a groundbreaking collaborative initiative, LADDIA, to accelerate AI-powered drug discovery for ALS and other neurodegenerative diseases. The partnership aims to identify and prioritize therapeutic targets using AI-driven insights from the largest open-access ALS dataset.
The 2025 Critical Path Institute Global Impact Conference will bring together industry, regulatory agencies, academia, and patient advocacy groups to discuss pressing challenges in drug development. The event aims to foster cross-sector collaboration to advance medical innovation and improve treatment outcomes for patients.
A new study published in Food & Function found that daily grape consumption improved muscle strength markers in postmenopausal women. The results suggest that incorporating grapes into the diet may offer an easy approach to mitigate sarcopenia, a condition with no effective treatment options.
Researchers investigated the link between HIV treatment regimens and osteoarthritis development, revealing that certain medications like lopinavir can exacerbate OA in the knee. The study's findings have important implications for people living with HIV, highlighting the need to carefully consider treatment options.
Researchers have discovered an oral drug called MA-5 that can improve both heart and muscle problems in patients with Barth syndrome, a rare genetic disorder. The drug boosts cellular energy production by up to 50% and protects cells from oxidative stress-induced death, addressing the underlying cause of the disease.
Researchers have identified a previously unknown organelle called the hemifusome that plays a crucial role in cellular sorting and recycling. This discovery could lead to targeted treatments for complex genetic disorders like Hermansky-Pudlak syndrome, which affects multiple systems in the body.
A $10m national effort led by SingHealth Duke-NUS Academic Medical Centre will advance understanding of sarcopenia in Asian populations and explore new methods of diagnosis and treatment. The initiative, MAGNET, has already recruited over 400 patients with sarcopenia for studies.
A new study from University of Illinois Chicago researchers suggests that poorly functioning blood vessels may be the cause of muscle wasting in cancer patients. The discovery could lead to the development of targeted therapies to restore blood vessel health and improve muscle strength.
A recent study suggests that 40% of US adults who currently smoke experience some level of functional difficulty, twice as high as those who have never smoked. The most common disabilities among smokers are mobility and cognitive issues.
Scientists have uncovered a previously unknown mechanism explaining how neurons survive botulinum neurotoxin type A exposure. The research found that specific tRNA fragments interact with key proteins and RNA molecules involved in regulating ferroptosis, supporting neuronal survival by blocking cell death pathways.
Estrogen-related receptors play a crucial role in regulating muscle cell metabolism and energy production. Researchers discovered that these receptors can increase mitochondrial numbers and enhance energetic output when muscles need more energy, making them a promising therapeutic target for metabolic disorders.
A team of researchers from Goethe University and Kiel University has discovered a way to prevent the formation of harmful protein aggregates in cultured cells. The study found that linking TDP-43 with SUMO prevents its aggregation, suggesting a potential new approach for treating ALS and other neurodegenerative diseases.
Dr. Elizabeth M. Curtis has been awarded the ESCEO-IOF Pierre Meunier Young Scientist Award for her groundbreaking research on musculoskeletal health and bone disease. Her work focuses on the epidemiology of bone, muscle health, and joint health across the lifespan.
Researchers at the University of Gothenburg have discovered a molecule that helps more mitochondria function properly, improving energy production in cells from patients with POLG mutations. This breakthrough paves the way for a new treatment strategy and may have broader therapeutic use for other mitochondrial diseases.
A national study in Australia aims to understand the genetic cause of rare diseases, improving diagnoses and treatment options for those affected. The study is recruiting Australians with a known or suspected rare genetic disease to gather information and connect them with future research opportunities.
Researchers at the University of Houston College of Pharmacy have identified a potential therapeutic target to repair injured muscles. They discovered that fibroblast growth factor–inducible 14 (Fn14) plays a crucial role in regulating satellite cell stability and function, which are responsible for muscle growth, repair, and regenerat...
Researchers at the University of Virginia Health System have developed a computational tool called LogiRx that can predict how drugs will affect biological processes in the body. The tool has demonstrated its potential by identifying a promising candidate to prevent heart failure, a leading cause of death worldwide.
Researchers found that p-tau proteins in blood are elevated in both Alzheimer's and ALS patients, making them less specific for Alzheimer's diagnosis. However, they also show promise as potential biomarkers for early detection of ALS or monitoring disease progression.
Researchers at USC Dornsife College of Letters, Arts and Sciences have made a breakthrough discovery about how tiny protein clusters form in cells. These nanoclusters play a crucial role in mechanotransduction, a process that fails in people with Emery-Dreifuss muscular dystrophy, leading to muscle weakness and heart problems.
Fibro-adipogenic progenitors (FAPs) influence muscle regeneration, fibrosis, and degeneration through inflammatory cytokines. IL-33 secreted by FAPs plays a crucial role in muscle injury repair and recruiting regulatory T cells.
A collaborative study reveals two distinct types of scarring, referred to as “hot” and “cold,” which require entirely different treatments for diseased hearts. The researchers found that hot fibrosis is driven by an immune response, while cold fibrosis is a self-maintaining process.
A clinical research team from HKUMed discovered a novel gene DDX39B linked to a rare neurodevelopmental syndrome, causing developmental delay and hypotonia. The study used multi-omics analysis and identified six patients worldwide with variations in the gene, providing crucial information for targeted diagnostic and treatment plans.
A global study analyzed brain images of over 2,500 people with Parkinson's disease to identify patterns of neurodegeneration and create metrics for each clinical stage. The research could lead to better diagnostic tools and enable new treatments to be tested and monitored.
A Michigan Medicine-led study suggests that living in disadvantaged communities may decrease the length of time a person can survive with amyotrophic lateral sclerosis (ALS) by up to 37%. The study found that patients from more resourced areas tended to live longer, possibly due to better access to care and reduced caregiver burnout. T...
A new drug-free intervention targets the root cause of progressive loss of neural function in SMA by gradually reawakening functionally silent motor neurons. Early results show improved leg muscle strength and walking in adults with SMA, regardless of symptom severity.
A new algorithm proposes measuring quadriceps muscle mass for more accurate sarcopenia diagnosis, potentially leading to earlier detection and better treatment options. Ultrasound imaging is recommended as a cost-effective and practical solution for diagnosing sarcopenia in clinical settings.
Researchers found AI-based imaging technology improves disease diagnosis accuracy, particularly in cardiology, oncology, neurology, and ophthalmology. The technology also enhances diagnostic efficiency and reduces healthcare disparities by delivering high-quality diagnostics to underserved areas.
Researchers discovered that removing arginase-II gene can slow down muscle aging in mice, leading to improved muscle health and reduced inflammation. This finding suggests targeting the Arg-II gene could help maintain muscle strength and mobility in older adults.
A new Dartmouth study reveals that 50% of adult blacklegged ticks in the Northeast carry the bacteria that causes Lyme disease. The study found small changes in tick abundance but a significant increase in pathogen prevalence over 30 years, highlighting the need for continued prevention measures.
Researchers document five cases of parvovirus B19-induced myocarditis in preschoolers from northern Greece, highlighting the virus's unique impact on endothelial cells. The study emphasizes the importance of quick diagnosis and treatment to reduce mortality and morbidity in children.